1. Home
  2. CYRX

as 09-17-2025 3:20pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Founded: 1999 Country:
United States
United States
Employees: N/A City: BRENTWOOD
Market Cap: 438.7M IPO Year: N/A
Target Price: $11.70 AVG Volume (30 days): 578.2K
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 1.35 EPS Growth: N/A
52 Week Low/High: $4.58 - $10.46 Next Earning Date: 11-06-2025
Revenue: $237,879,000 Revenue Growth: 24.93%
Revenue Growth (this year): -23.87% Revenue Growth (next year): 9.08%

CYRX Daily Stock ML Predictions

Stock Insider Trading Activity of CryoPort Inc. (CYRX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Hariri Robert J CYRX Director Sep 11 '25 Sell $9.71 25,000 $242,737.50 51,275
STEFANOVICH ROBERT CYRX Chief Financial Officer Aug 19 '25 Sell $8.67 9,300 $80,617.98 207,213
Mandalam Ramkumar CYRX Director Jun 24 '25 Sell $7.02 13,321 $93,446.82 73,056
SHELTON JERRELL CYRX President, CEO Jun 24 '25 Sell $7.06 16,344 $115,365.76 912,419

Share on Social Networks: